FDA Adverse Event Malfunction Summary report: N

CLINICAL CHEMISTRY ALKALINE PHOSPHATASE REAGENT

MDR report key: 2246077 · Received September 13, 2011

Report

Report Number
1628664-2011-00608
Event Type
Malfunction
Date Received
September 13, 2011
Report Date
August 8, 2011
Manufacturer
ABBOTT MANUFACTURING INC
Product Code
CJE
PMA / PMN Number
K981806
Removal / Correction Number
1628664-8/29/11-001-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PATIENT: NO CONSEQUENCES OR IMPACT TO PATIENT (B)(6); (B)(4) DEVICE: CONTAMINATION DURING USE (B)(4). THE CAUSE OF THE CLINICAL CHEMISTRY ALKALINE PHOSPHATASE REAGENTS FAILED TO CALIBRATE/GENERATE RESULTS WAS DUE TO VISIBLE PARTICULATE OR VISIBLE MOLD IN THE REAGENT CARTRIDGES. ABBOTT ISSUED A PRODUCT RECALL LETTER TO ALL CUSTOMERS TO INFORM THEM TO DISCONTINUE USE AND TO DISCARD/DESTROY ANY SUSPECT CARTRIDGES AND ORDER REPLACEMENT REAGENTS.

Description of Event or Problem · 1

THE CUSTOMER CONFIRMED THERE WAS AN INCREASE OF PATIENT EXCEPTIONS ON READS WERE THE ABSORBANCE WAS TOO HIGH WHILE CLINICAL CHEMISTRY ALKALINE PHOSPHATASE REAGENT LOT 62474UN10 WAS IN USE, ALTHOUGH ASSAY MEANS, SD AND %CV WERE WITHIN THE LAB'S ACCEPTABLE LIMITS. THE CUSTOMER REJECTED CLINICAL CHEMISTRY ALKALINE PHOSPHATASE REAGENT LOT 62474UN10 DUE TO FUNGAL GROWTH FOUND IN RANDOM REAGENT CARTRIDGES. THERE WAS NO IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CLINICAL CHEMISTRY ALKALINE PHOSPHATASE REAGENT CJE ABBOTT MANUFACTURING INC 62474UN10

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT C16000, LIST # 3L77-01, SERIAL # (B)(4)